Search

Your search keyword '"Stuessi, Georg"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Stuessi, Georg" Remove constraint Author: "Stuessi, Georg"
25 results on '"Stuessi, Georg"'

Search Results

1. Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

2. Genetic and phenotypic attributes of splenic marginal zone lymphoma

4. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

7. Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

8. Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with AML and high risk MDS

9. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)

11. Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

12. Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

13. Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance

14. Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial

15. CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway

16. Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway

17. A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression

18. Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012

19. Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma

20. Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013

21. International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

22. Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland Between 2001 and 2012

23. Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2-Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

24. Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy

25. Analysis of the Early Clonal Dynamics in Ibrutinib-Treated Chronic Lymphocytic Leukemia

Catalog

Books, media, physical & digital resources